# Optimizing Dosing Strategies in Oral Iron Supplementation

> **NCT06238895** · PHASE4 · COMPLETED · sponsor: **Luzerner Kantonsspital** · enrollment: 29 (actual)

## Conditions studied

- Iron Deficiencies
- Iron Deficiency Anemia
- Iron Deficiency Anemia Treatment

## Interventions

- **DRUG:** Tardyferon

## Key facts

- **NCT ID:** NCT06238895
- **Lead sponsor:** Luzerner Kantonsspital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-01
- **Primary completion:** 2025-11-18
- **Final completion:** 2025-11-18
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06238895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06238895, "Optimizing Dosing Strategies in Oral Iron Supplementation". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06238895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*